Treatment Landscape of Macular Disorders in Indian Patients with the Advent of Razumab™ (World’s First Biosimilar Ranibizumab): A Comprehensive Review-Reference-Cited by-同舟云学术

Treatment Landscape of Macular Disorders in Indian Patients with the Advent of Razumab™ (World’s First Biosimilar Ranibizumab): A Comprehensive Review

Published:2021-06-21 Issue:3 Volume:10 Page:431-443
ISSN:2193-8245
Container-title:Ophthalmology and Therapy
language:en
Short-container-title:Ophthalmol Ther

Author:

Sharma Shashikant^ORCID,Sharma Tanishq,Prasad Somdutt,Gopalakrishnan Mahesh,Chaturvedi Alok

Publisher

Springer Science and Business Media LLC

Subject

Ophthalmology

Link

https://link.springer.com/content/pdf/10.1007/s40123-021-00362-1.pdf

Reference81 articles.

1. Neely KA, Gardner TW. Ocular neovascularization: clarifying complex interactions. Am J Pathol. 1998;153(3):665–70.

2. Sameera VV, Ayachit A, Joshi S, Guruprasad AS. Safety and efficacy of Razumab—the new biosimilar in India: our experience. Kerala J Ophthalmol. 2016;28(28):180.

3. Alexandru MR, Alexandra NM. Wet age related macular degeneration management and follow-up. Rom J Ophthalmol. 2016;60(1):9–13.

4. Ayoub T, Patel N. Age-related macular degeneration. J R Soc Med. 2009;102(2):56–61.

5. Danyliv A, Glanville J, McCool R, et al. The clinical effectiveness of ranibizumab treat and extend regimen in nAMD: systematic review and network meta-analysis. Adv Ther. 2017;34(3):611–9.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systematic review of efficacy and meta-analysis of safety of ranibizumab biosimilars relative to reference ranibizumab anti-VEGF therapy for nAMD treatment;BMJ Open Ophthalmology;2023-06

2. Effects of Ranibizumab combined with laser photocoagulation on macular volume and best corrected visual acuity in patients with macular edema secondary to ischemic retinal vein occlusion;Pakistan Journal of Medical Sciences;2023-01-28

3. Ranibizumab Biosimilars for Neovascular Age-related Macular Degeneration, Macular Oedema with Retinal Vein Occlusion and Myopic Choroidal Neovascularization;US Ophthalmic Review;2022